![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: AQP3 |
Gene summary for AQP3 |
![]() |
Gene information | Species | Human | Gene symbol | AQP3 | Gene ID | 360 |
Gene name | aquaporin 3 (Gill blood group) | |
Gene Alias | AQP-3 | |
Cytomap | 9p13.3 | |
Gene Type | protein-coding | GO ID | GO:0001666 | UniProtAcc | Q92482 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
360 | AQP3 | GSM5252134_BPH511PrG_Fcol_3GEX | Human | Prostate | BPH | 2.11e-03 | 6.88e-01 | -0.1433 |
360 | AQP3 | GSM5252135_BPH511PrPUr_Fcol_3GEX | Human | Prostate | BPH | 2.67e-28 | 3.55e+00 | -0.1833 |
360 | AQP3 | GSM5252137_BPH556PrGA2_Fcol | Human | Prostate | BPH | 1.42e-03 | 6.13e-01 | -0.23 |
360 | AQP3 | 047563_1562-all-cells | Human | Prostate | BPH | 1.31e-12 | -4.26e-01 | 0.0791 |
360 | AQP3 | 048752_1579-all-cells | Human | Prostate | BPH | 6.42e-03 | -3.68e-01 | 0.1008 |
360 | AQP3 | 052095_1628-all-cells | Human | Prostate | BPH | 1.21e-10 | -5.41e-01 | 0.1032 |
360 | AQP3 | 052097_1595-all-cells | Human | Prostate | BPH | 1.24e-02 | -4.19e-01 | 0.0972 |
360 | AQP3 | 052099_1652-all-cells | Human | Prostate | BPH | 7.62e-17 | -6.92e-01 | 0.1038 |
360 | AQP3 | Dong_P1 | Human | Prostate | Tumor | 1.70e-21 | -3.83e-01 | 0.035 |
360 | AQP3 | Dong_P3 | Human | Prostate | Tumor | 3.64e-19 | -2.58e-01 | 0.0278 |
360 | AQP3 | Dong_P4 | Human | Prostate | Tumor | 2.00e-05 | -9.01e-02 | 0.0292 |
360 | AQP3 | Dong_P5 | Human | Prostate | Tumor | 1.40e-51 | -9.95e-01 | 0.053 |
360 | AQP3 | Dong_P6 | Human | Prostate | Tumor | 2.92e-06 | -7.72e-01 | 0.0371 |
360 | AQP3 | P9 | Human | Prostate | Tumor | 1.16e-09 | -8.41e-01 | -0.0285 |
360 | AQP3 | GSM5353227_PA_PR5199-193K_Pool_1_2_3_S55_L002 | Human | Prostate | Tumor | 5.50e-04 | -6.70e-01 | 0.1602 |
360 | AQP3 | GSM5353243_PA_PR5261_T1_S23_L002 | Human | Prostate | Tumor | 1.32e-05 | -3.10e-01 | 0.1545 |
360 | AQP3 | P1_S1_AK | Human | Skin | AK | 4.32e-04 | -1.02e-01 | -0.3399 |
360 | AQP3 | P2_S3_AK | Human | Skin | AK | 4.19e-11 | -2.05e-01 | -0.3287 |
360 | AQP3 | P3_S6_AK | Human | Skin | AK | 1.34e-02 | 7.93e-02 | -0.3256 |
360 | AQP3 | P4_S8_cSCC | Human | Skin | cSCC | 6.67e-22 | 6.93e-01 | -0.3095 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00085446 | Cervix | CC | epidermis development | 83/2311 | 324/18723 | 3.91e-11 | 8.54e-09 | 83 |
GO:00435884 | Cervix | CC | skin development | 71/2311 | 263/18723 | 8.04e-11 | 1.46e-08 | 71 |
GO:007149610 | Cervix | CC | cellular response to external stimulus | 78/2311 | 320/18723 | 1.82e-09 | 1.98e-07 | 78 |
GO:00302164 | Cervix | CC | keratinocyte differentiation | 42/2311 | 139/18723 | 1.74e-08 | 1.28e-06 | 42 |
GO:00099137 | Cervix | CC | epidermal cell differentiation | 53/2311 | 202/18723 | 5.48e-08 | 3.25e-06 | 53 |
GO:00316689 | Cervix | CC | cellular response to extracellular stimulus | 59/2311 | 246/18723 | 3.03e-07 | 1.24e-05 | 59 |
GO:005087810 | Cervix | CC | regulation of body fluid levels | 78/2311 | 379/18723 | 3.20e-06 | 8.77e-05 | 78 |
GO:00456822 | Cervix | CC | regulation of epidermis development | 22/2311 | 65/18723 | 5.56e-06 | 1.38e-04 | 22 |
GO:003166710 | Cervix | CC | response to nutrient levels | 92/2311 | 474/18723 | 5.80e-06 | 1.42e-04 | 92 |
GO:00456042 | Cervix | CC | regulation of epidermal cell differentiation | 20/2311 | 58/18723 | 1.07e-05 | 2.33e-04 | 20 |
GO:00316698 | Cervix | CC | cellular response to nutrient levels | 49/2311 | 215/18723 | 1.32e-05 | 2.68e-04 | 49 |
GO:00456163 | Cervix | CC | regulation of keratinocyte differentiation | 14/2311 | 37/18723 | 6.97e-05 | 9.81e-04 | 14 |
GO:00308563 | Cervix | CC | regulation of epithelial cell differentiation | 36/2311 | 154/18723 | 1.02e-04 | 1.31e-03 | 36 |
GO:000166610 | Cervix | CC | response to hypoxia | 61/2311 | 307/18723 | 1.04e-04 | 1.34e-03 | 61 |
GO:007048210 | Cervix | CC | response to oxygen levels | 67/2311 | 347/18723 | 1.21e-04 | 1.51e-03 | 67 |
GO:003629310 | Cervix | CC | response to decreased oxygen levels | 62/2311 | 322/18723 | 2.29e-04 | 2.57e-03 | 62 |
GO:00714539 | Cervix | CC | cellular response to oxygen levels | 38/2311 | 177/18723 | 4.23e-04 | 4.27e-03 | 38 |
GO:00362949 | Cervix | CC | cellular response to decreased oxygen levels | 35/2311 | 161/18723 | 5.49e-04 | 5.29e-03 | 35 |
GO:00714566 | Cervix | CC | cellular response to hypoxia | 33/2311 | 151/18723 | 7.06e-04 | 6.41e-03 | 33 |
GO:001003810 | Cervix | CC | response to metal ion | 67/2311 | 373/18723 | 9.67e-04 | 8.10e-03 | 67 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa049624 | Liver | HCC | Vasopressin-regulated water reabsorption | 30/4020 | 44/8465 | 4.41e-03 | 1.32e-02 | 7.34e-03 | 30 |
hsa0496211 | Liver | HCC | Vasopressin-regulated water reabsorption | 30/4020 | 44/8465 | 4.41e-03 | 1.32e-02 | 7.34e-03 | 30 |
hsa049625 | Prostate | BPH | Vasopressin-regulated water reabsorption | 17/1718 | 44/8465 | 3.88e-03 | 1.39e-02 | 8.61e-03 | 17 |
hsa0496212 | Prostate | BPH | Vasopressin-regulated water reabsorption | 17/1718 | 44/8465 | 3.88e-03 | 1.39e-02 | 8.61e-03 | 17 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
AQP3 | SNV | Missense_Mutation | novel | c.632G>A | p.Gly211Asp | p.G211D | Q92482 | protein_coding | deleterious(0.01) | benign(0.347) | TCGA-A2-A04Q-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
AQP3 | SNV | Missense_Mutation | c.404N>G | p.Leu135Arg | p.L135R | Q92482 | protein_coding | deleterious(0) | possibly_damaging(0.887) | TCGA-A6-6649-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | SD | |
AQP3 | SNV | Missense_Mutation | c.483N>A | p.Phe161Leu | p.F161L | Q92482 | protein_coding | deleterious(0.05) | probably_damaging(0.998) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
AQP3 | SNV | Missense_Mutation | rs756008789 | c.583G>A | p.Val195Met | p.V195M | Q92482 | protein_coding | deleterious(0.01) | probably_damaging(0.969) | TCGA-AZ-4313-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
AQP3 | SNV | Missense_Mutation | rs760141667 | c.556G>A | p.Val186Ile | p.V186I | Q92482 | protein_coding | tolerated(0.47) | benign(0.01) | TCGA-CK-6747-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
AQP3 | SNV | Missense_Mutation | rs762587298 | c.767N>T | p.Ala256Val | p.A256V | Q92482 | protein_coding | tolerated(0.78) | benign(0.003) | TCGA-AJ-A3BH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
AQP3 | SNV | Missense_Mutation | novel | c.418N>A | p.Pro140Thr | p.P140T | Q92482 | protein_coding | deleterious(0.04) | benign(0.044) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
AQP3 | SNV | Missense_Mutation | c.754N>A | p.Leu252Met | p.L252M | Q92482 | protein_coding | deleterious(0.05) | probably_damaging(0.967) | TCGA-D1-A17D-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | |
AQP3 | SNV | Missense_Mutation | novel | c.290N>T | p.Pro97Leu | p.P97L | Q92482 | protein_coding | deleterious(0.01) | possibly_damaging(0.87) | TCGA-EC-A24G-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
AQP3 | SNV | Missense_Mutation | rs749786864 | c.413C>T | p.Ser138Leu | p.S138L | Q92482 | protein_coding | deleterious(0.04) | benign(0.011) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
360 | AQP3 | ION CHANNEL, TRANSPORTER | inhibitor | 381118898 | AUPHEN | |
360 | AQP3 | ION CHANNEL, TRANSPORTER | inhibitor | 178101032 | ||
360 | AQP3 | ION CHANNEL, TRANSPORTER | inhibitor | 381118899 |
Page: 1 |